PANACEA BIOTEC
Back to Balance Sheet
|
PANACEA BIOTEC Last 5 Year Total Current Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Current Liabilities | ₹367 Cr | ₹309 Cr | ₹330 Cr | ₹774 Cr | ₹447 Cr |
What is the latest Total Current Liabilities ratio of PANACEA BIOTEC ?
| Year | Total Current Liabilities |
|---|---|
| Mar2025 | ₹367 Cr |
| Mar2024 | ₹309 Cr |
| Mar2023 | ₹330 Cr |
| Mar2022 | ₹774 Cr |
| Mar2021 | ₹447 Cr |
How is Total Current Liabilities of PANACEA BIOTEC Trending?
| Years | Total Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹367 Cr | 18.77 | |
| Mar2024 | ₹309 Cr | -6.29 | |
| Mar2023 | ₹330 Cr | -57.39 | |
| Mar2022 | ₹774 Cr | 73.01 | |
| Mar2021 | ₹447 Cr | - | |
Compare Total Current Liabilities of peers of PANACEA BIOTEC
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| PANACEA BIOTEC | ₹3,386.8 Cr | 3.9% | 31.9% | 20.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹448,148.0 Cr | 2.6% | 1.2% | 13% | Stock Analytics | |
| DIVIS LABORATORIES | ₹179,009.0 Cr | 1.3% | -2.1% | 3.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹152,779.0 Cr | 1.5% | 0.7% | 37.1% | Stock Analytics | |
| CIPLA | ₹115,772.0 Cr | 6.1% | 2.4% | -5.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹108,616.0 Cr | 2.6% | -0.4% | -2.1% | Stock Analytics | |
PANACEA BIOTEC Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| PANACEA BIOTEC | 3.9% |
31.9% |
20.2% |
| SENSEX | -0.8% |
1.4% |
-6.8% |
You may also like the below Video Courses